Literature DB >> 2995183

HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects.

O Bruserud, J Jervell, E Thorsby.   

Abstract

To study the relationships between the responses to viral antigens and the HLA-DR3 and -DR4 associations in Type 1 (insulin-dependent) diabetes mellitus, the frequency of T-lymphocyte proliferating in response to mumps, Coxsackie B4 and varicella-zoster antigens was determined. A decreased frequency was found in T lymphocytes able to respond to mumps or Coxsackie B4 when presented together with DR3, as compared with the frequency of T lymphocytes able to respond to these viruses together with other DR determinants. This was not found for varicella-zoster or purified protein derivative of tuberculin. In contrast, an increased frequency was found in T lymphocytes responding to mumps or Coxsackie B4 together with DR4, compared with other DR determinants. The results were similar in Type 1 diabetic and healthy individuals. The results suggest that elements on the DR3 and DR4 molecules may control T-lymphocyte responses to mumps and Coxsackie B4 viruses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995183     DOI: 10.1007/bf00280884

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

1.  Is mumps virus an etiologic factor in juvenile diabetes mellitus.

Authors:  H A Sultz; B A Hart; M Zielezny; E R Schlesinger
Journal:  J Pediatr       Date:  1975-04       Impact factor: 4.406

2.  Long-term maintenance of HLA-D restricted T cells specific for soluble antigens.

Authors:  J T Kurnick; P Altevogt; J Lindblom; O Sjöberg; A Danneus; H Wigzell
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

3.  Infection of human pancreatic beta cell cultures with mumps virus.

Authors:  G A Prince; A B Jenson; L C Billups; A L Notkins
Journal:  Nature       Date:  1978-01-12       Impact factor: 49.962

4.  Islet cell antibodies in children with mumps infection.

Authors:  K Helmke; A Otten; W Willems
Journal:  Lancet       Date:  1980-07-26       Impact factor: 79.321

5.  The role of HLA in T cell activation.

Authors:  E Thorsby
Journal:  Hum Immunol       Date:  1984-01       Impact factor: 2.850

6.  HLA-D/DR restriction of proliferative T cell responses to antigen. Enrichment of antigen-specific T cell blasts and evidence of preferential HLA-D/DR restriction.

Authors:  E J Berle; A B Thoresen; E Thorsby
Journal:  Tissue Antigens       Date:  1982-11

7.  HLA and diseases: involvement of more than one HLA-linked determinant of disease susceptibility.

Authors:  S Scholz; E Albert
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

8.  HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families.

Authors:  L Contu; I Deschamps; H Lestradet; J Hors; M Schmid; M Busson; A Benajam; A Marcelli-Barge; J Dausset
Journal:  Tissue Antigens       Date:  1982-08

9.  Prolonged breast feeding as prophylaxis for recurrent otitis media.

Authors:  U M Saarinen
Journal:  Acta Paediatr Scand       Date:  1982-07

10.  Quantitative studies of alloantigen-reactive human lymphocytes in primary and secondary MLC.

Authors:  D P Singal
Journal:  Hum Immunol       Date:  1980-07       Impact factor: 2.850

View more
  8 in total

1.  Genes mediating environment interactions in type 1 diabetes.

Authors:  Erik Biros; Margaret A Jordan; Alan G Baxter
Journal:  Rev Diabet Stud       Date:  2006-02-10

2.  Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation.

Authors:  H Viskari; J Ludvigsson; R Uibo; L Salur; D Marciulionyte; R Hermann; G Soltesz; M Füchtenbusch; A-G Ziegler; A Kondrashova; A Romanov; B Kaplan; Z Laron; P Koskela; T Vesikari; H Huhtala; M Knip; H Hyöty
Journal:  Diabetologia       Date:  2005-05-19       Impact factor: 10.122

3.  Comparison of enterovirus-specific cellular immunity in two populations of young children vaccinated with inactivated or live poliovirus vaccines.

Authors:  S Juhela; H Hyöty; R Uibo; S H Meriste; O Uibo; M Lönnrot; M Halminen; O Simell; J Ilonen
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

4.  The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens.

Authors:  K Sadeharju; M Knip; M Hiltunen; H K Akerblom; H Hyöty
Journal:  Diabetologia       Date:  2003-07-05       Impact factor: 10.122

5.  Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group.

Authors:  H Hyöty; M Hiltunen; A Reunanen; P Leinikki; T Vesikari; R Lounamaa; J Tuomilehto; H K Akerblom
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

6.  Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.

Authors:  B Michelsen; A Lernmark
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

7.  Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.

Authors:  J Karjalainen; M Knip; H Hyöty; P Leinikki; J Ilonen; M L Käär; H K Akerblom
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

8.  Maternal enterovirus infection as a risk factor for type 1 diabetes in the exposed offspring.

Authors:  Hanna Viskari; Mikael Knip; Sisko Tauriainen; Heini Huhtala; Riitta Veijola; Jorma Ilonen; Olli Simell; Heljä-Marja Surcel; Heikki Hyöty
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.